| scholarly article | Q13442814 |
| P50 | author | Michael S. Diamond | Q28051146 |
| Stephen Higgs | Q28320183 | ||
| Dana Vanlandingham | Q29381208 | ||
| Julie M. Fox | Q55190881 | ||
| Thomas E Morrison | Q66829484 | ||
| Yan-Jang S Huang | Q84767331 | ||
| Ilhem Messaoudi | Q87616701 | ||
| David W Hawman | Q97635567 | ||
| P2093 | author name string | Syd Johnson | |
| Alfred W Legasse | |||
| Craig Kreklywich | |||
| Daniel N Streblow | |||
| Michael Denton | |||
| Michael K Axthelm | |||
| Pankaj Pal | |||
| Patricia P Smith | |||
| P2860 | cites work | Structural analyses at pseudo atomic resolution of Chikungunya virus and antibodies show mechanisms of neutralization | Q21128795 |
| A single mutation in chikungunya virus affects vector specificity and epidemic potential | Q21131599 | ||
| A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease | Q21559504 | ||
| Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study | Q21562246 | ||
| Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages | Q24288996 | ||
| Spread of the tiger: global risk of invasion by the mosquito Aedes albopictus | Q24289219 | ||
| Re-emergence of Chikungunya and O'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships | Q24570057 | ||
| Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock | Q24598171 | ||
| Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor | Q24625887 | ||
| Type I IFN controls chikungunya virus via its action on nonhematopoietic cells | Q24647231 | ||
| Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus | Q27335008 | ||
| The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic | Q27469278 | ||
| Promoter for Sindbis virus RNA-dependent subgenomic RNA transcription | Q27486576 | ||
| Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies | Q27486933 | ||
| Mapping the Structure and Function of the E1 and E2 Glycoproteins in Alphaviruses | Q27489867 | ||
| The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH | Q27631190 | ||
| Structural changes of envelope proteins during alphavirus fusion | Q27666145 | ||
| Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography | Q27666147 | ||
| A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease | Q28533408 | ||
| Infection with chikungunya virus in Italy: an outbreak in a temperate region | Q29346487 | ||
| Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus | Q29620003 | ||
| A humanized murine monoclonal antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus | Q33253169 | ||
| Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency | Q33806890 | ||
| Chikungunya outbreaks--the globalization of vectorborne diseases | Q34002554 | ||
| Replication cycle of chikungunya: a re-emerging arbovirus | Q34042046 | ||
| Chikungunya virus arthritis in adult wild-type mice | Q34046030 | ||
| ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation | Q34058142 | ||
| Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response | Q34110965 | ||
| Cutting edge: independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to Chikungunya infection | Q34257289 | ||
| Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein | Q34264257 | ||
| Arthritogenic alphaviruses--an overview | Q34273343 | ||
| A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice | Q34315384 | ||
| Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response | Q34378105 | ||
| Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virus | Q34391631 | ||
| Infectious clones of Chikungunya virus (La Réunion isolate) for vector competence studies | Q34594476 | ||
| Chikungunya in north-eastern Italy: a summing up of the outbreak. | Q34720609 | ||
| A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence | Q34756658 | ||
| Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity | Q34927480 | ||
| Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design | Q35109218 | ||
| Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants | Q35586877 | ||
| Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate. | Q36200552 | ||
| Chikungunya virus and prospects for a vaccine | Q36582816 | ||
| An essential role of antibodies in the control of Chikungunya virus infection | Q36914762 | ||
| Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis | Q37331952 | ||
| Chikungunya fever: an epidemiological review of a re-emerging infectious disease | Q37575480 | ||
| Emergence and clinical insights into the pathology of Chikungunya virus infection | Q37785544 | ||
| Chikungunya-related arthritis: case report and review of the literature | Q38100901 | ||
| Chikungunya and dengue autochthonous cases in Europe, 2007-2012. | Q38130346 | ||
| A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization | Q38329445 | ||
| Use of human monoclonal antibodies to treat Chikungunya virus infection | Q39012242 | ||
| Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice | Q40254655 | ||
| Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides broad protection, in murine models, against airborne challenge with viruses from serogroups I, II and III. | Q40290968 | ||
| Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis | Q40313646 | ||
| Monoclonal antibodies that cross-react with the E1 glycoprotein of different alphavirus serogroups: characterization including passive protection in vivo | Q41836576 | ||
| Tracking epidemic Chikungunya virus into the Indian Ocean from East Africa | Q42062705 | ||
| Neutralizing monoclonal antibodies to the E2 protein of chikungunya virus protects against disease in a mouse model | Q42240413 | ||
| Genetic divergence of Chikungunya viruses in India (1963-2006) with special reference to the 2005-2006 explosive epidemic | Q42623122 | ||
| Structure and interactions at the viral surface of the envelope protein E1 of Semliki Forest virus | Q42677821 | ||
| Chikungunya in Europe | Q43046500 | ||
| Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island | Q44851009 | ||
| An animal model for studying the pathogenesis of chikungunya virus infection | Q44851012 | ||
| Chikungunya in Europe. | Q44851114 | ||
| Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis | Q45793971 | ||
| Host defenses during primary Venezuelan equine encephalomyelitis virus infection in mice. I. Passive transfer of protection with immune serum and immune cells | Q45819843 | ||
| Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. III. Identification of a protective peptide derived from the carboxy-terminal extramembranal one-third of the protein | Q45853854 | ||
| Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis | Q59070308 | ||
| Antibody-mediated clearance of alphavirus infection from neurons | Q68262671 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| chikungunya | Q243257 | ||
| Chikungunya virus | Q15794049 | ||
| monoclonal antibody | Q422248 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 8213-26 | |
| P577 | publication date | 2014-08-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes | |
| P478 | volume | 88 |
| Q30240216 | Animal Models of Chikungunya Virus Infection and Disease. |
| Q89794663 | Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection |
| Q66680697 | Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus |
| Q36318652 | Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress |
| Q58575620 | Cellular and Molecular Immune Response to Chikungunya Virus Infection |
| Q38874607 | Chikungunya Virus: Current Perspectives on a Reemerging Virus. |
| Q44843465 | Chikungunya Virus: Pathophysiology, Mechanism, and Modeling |
| Q26700081 | Chikungunya vaccines in development |
| Q30235512 | Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies |
| Q94561515 | Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections |
| Q24701766 | Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy |
| Q78177480 | Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins. |
| Q54247380 | Human-Like Neutralizing Antibodies Protect Mice from Aerosol Exposure with Western Equine Encephalitis Virus. |
| Q39038535 | IgG Fc variant cross-reactivity between human and rhesus macaque FcγRs |
| Q39013750 | Immune-Mediated Protection and Pathogenesis of Chikungunya Virus |
| Q35850197 | Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus |
| Q40077669 | Monoclonal Antibodies as Prophylactic and Therapeutic Agents Against Chikungunya Virus |
| Q40656589 | Mouse Models of Chikungunya Virus |
| Q92133744 | Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity |
| Q26782722 | Nonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model) |
| Q91842996 | Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes |
| Q59350546 | Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein |
| Q35861232 | Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists |
| Q33853893 | Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques |
| Q91605138 | Therapeutic monoclonal antibody treatment protects nonhuman primates from severe Venezuelan equine encephalitis virus disease after aerosol exposure |
| Q62737885 | Tropism of the Chikungunya Virus |
| Q38157882 | Vertebrate Reservoirs of Arboviruses: Myth, Synonym of Amplifier, or Reality? |
| Q28954543 | Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues |
Search more.